AARD
Aardvark Therapeutics, Inc.Company with tickers: AARD
CIK
1774857
CUSIP
002942100
Shares Outstanding
21,816,385
13F Activity (30d)
72 filings
72 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $10,470,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $7,755,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-10,470,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-9,310,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.71 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.71 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |